Cargando…
Expression and Prognostic Significance of CD47–SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer
Despite the confirmed anti-cancer effects of T-cell immune checkpoint inhibitors, in colorectal cancer (CRC) they are only effective in a small subset of patients with microsatellite-unstable tumors. Thus, therapeutics targeting other types of CRCs or tumors refractory to T-cell checkpoint inhibitor...
Autores principales: | Sugimura-Nagata, Akane, Koshino, Akira, Inoue, Satoshi, Matsuo-Nagano, Aya, Komura, Masayuki, Riku, Miho, Ito, Hideaki, Inoko, Akihito, Murakami, Hideki, Ebi, Masahide, Ogasawara, Naotaka, Tsuzuki, Toyonori, Takahashi, Satoru, Kasugai, Kunio, Kasai, Kenji, Inaguma, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975978/ https://www.ncbi.nlm.nih.gov/pubmed/33799989 http://dx.doi.org/10.3390/ijms22052690 |
Ejemplares similares
-
SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer
por: Sugimura-Nagata, Akane, et al.
Publicado: (2022) -
The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer
por: Nagao, Kazuhiro, et al.
Publicado: (2022) -
PBK Enhances Cellular Proliferation With Histone H3 Phosphorylation and Suppresses Migration and Invasion With CDH1 Stabilization in Colorectal Cancer
por: Koshino, Akira, et al.
Publicado: (2022) -
Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer
por: Ueki, Akane, et al.
Publicado: (2023) -
Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer
por: Inoue, Satoshi, et al.
Publicado: (2020)